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Abstract
In this review, we outline the current trends in the field of machine learning-driven classification studies related to ADME 
(absorption, distribution, metabolism and excretion) and toxicity endpoints from the past six years (2015–2021). The study 
focuses only on classification models with large datasets (i.e. more than a thousand compounds). A comprehensive litera-
ture search and meta-analysis was carried out for nine different targets: hERG-mediated cardiotoxicity, blood–brain barrier 
penetration, permeability glycoprotein (P-gp) substrate/inhibitor, cytochrome P450 enzyme family, acute oral toxicity, muta-
genicity, carcinogenicity, respiratory toxicity and irritation/corrosion. The comparison of the best classification models was 
targeted to reveal the differences between machine learning algorithms and modeling types, endpoint-specific performances, 
dataset sizes and the different validation protocols. Based on the evaluation of the data, we can say that tree-based algorithms 
are (still) dominating the field, with consensus modeling being an increasing trend in drug safety predictions. Although one 
can already find classification models with great performances to hERG-mediated cardiotoxicity and the isoenzymes of the 
cytochrome P450 enzyme family, these targets are still central to ADMET-related research efforts.
Graphical abstract
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Introduction
In the past decade, machine learning (ML) has under-
gone a definite revival in connection to the emergence of 
big data and the increase of compute capacities. Some 
maintain that big data have the potential to challenge the 
 * Anita Rácz 
 racz.anita@ttk.hu
 * Károly Héberger 
 heberger.karoly@ttk.hu
Extended author information available on the last page of the article
1410 Molecular Diversity (2021) 25:1409–1424
1 3
scientific method itself for new discoveries in science, 
through studying data correlations at a large scale [1]. 
Either way, present computer facilities allow us to analyze 
larger and larger data sets. As the computer power (speed 
and amount of data) increased, machine learning algo-
rithms proliferated and artificial neural networks (ANNs) 
achieved a renaissance, their key role being further under-
lined by the appearance of deep learning methods to han-
dle previously unprecedented amounts of data [2]. A con-
solidated description of big data is given by integrating 
definitions from practitioners and academics, and mainly 
deals with analytics related to unstructured data, which 
constitute 95% of big data [3].
In computer-aided drug design, the application of 
machine learning methods constitutes the new generation 
of QSAR modeling, although with the larger amount of 
training data (wider applicability domain) most authors 
aim for developing classification, rather than regression 
models. Recently, Maran et  al. have reviewed a large 
amount of QSAR articles (1 533) on 79 individual end-
points of environmental and medicinal chemistry rele-
vance, from all years up until 2015 [4]. From this plethora 
of QSAR studies 1235 contained multiple linear regression 
(MLR) modeling, 226 ANN, 77 support vector machines 
(SVM), 42 k-nearest neighbors (kNN), 39 decision trees 
(DT), 35 random forests (RF) and a few others. On one 
hand, it shows the unchallenged leading role of MLR in 
the previous decades of QSAR modeling; on the other 
hand, it reveals the significant effect of the machine learn-
ing revolution that is still going on.
Parallel to the unshaken popularity of linear modeling, 
an unprecedented proliferation of nonlinear machine learn-
ing algorithms took place. The present work, as well as 
other surveys show the most frequently used ML tech-
niques: tree-based methods (e.g., random forest, bagging, 
boosting and their variants), extensions of artificial neu-
ral networks (e.g., deep leaning networks, DNN), support 
vector machines (SVM), k-nearest neighbors (kNN) and 
Naïve Bayes (NB). The latter two techniques are involved 
as standard, classical, well-known techniques mainly 
for benchmarking; on the other hand, SVM, tree-based 
algorithms and neural networks are trending now in all 
aspects of data science. ML algorithms are routinely used 
in (i) bioactivity [5], as well as property predictions of 
drug related compounds [6]; (ii) de novo drug design, i.e., 
generation of new chemical structures of practical inter-
est [7]; (iii) virtual screening [8]; (iv) prediction of reac-
tion pathways [9] and v) compound-protein interactions 
[10], etc. ML algorithms are mainly aimed at prediction, 
for which a great selection of descriptors and chemical 
representations, as well as many ML algorithms can be 
combined [11]. ML models are trained to recognize struc-
tural patterns that differentiate between active and inactive 
compounds. Understanding the reasons why models are so 
effective in prediction is a challenging task but of utmost 
importance to guide drug design [12].
As ML algorithms are easily overfitted, proper validation 
is of crucial importance. It is an eye-opening conclusion of 
the review of Maran et al. that reproducible studies (615) 
are in minority as compared the non-reproducible studies 
(882) [4]. Although there is no silver bullet that will always 
produce a reliable estimation of prediction error, a combina-
tion of cross-validation techniques achieves consolidated and 
superb performance in the prediction of unknowns. There 
are many known and accepted ways for the validation of ML 
models, such as i) randomization (permutation) tests [13]; 
ii) the many variants of cross-validation, such as row-wise, 
pattern-wise, Venetian blinds, contiguous blocks, etc.[14].; 
iii) repeated double cross-validation [15] iv) internal and 
external test validation and others. A statistical comparison 
of cross-validation variants for classification was published 
recently [16].
ADMET (absorption, distribution, metabolism, excretion 
and toxicity) properties are crucial for drug design, as they 
can make or break (usually break) the career of drug candi-
dates. Due to their central role, the present review will con-
centrate on collecting machine learning classification studies 
of ADMET-related targets in the last five years, providing a 
meta-analysis of nine important ADMET endpoints.
Methods
In the past decades, artificial intelligence has escaped the 
world of science fiction and became a ubiquitous, albeit 
often hidden, part of our lives. While the self-definition of 
the field for intelligent agents (autonomous units capable 
of reacting to environmental changes for a specific goal) is 
very broad and includes such everyday devices as a simple 
thermostat, people usually associate artificial intelligence 
with more complex systems. A prime example for the latter 
is machine learning, which gradually became a dominating 
approach in many scientific areas including classification, 
especially in the case of large datasets. There are several 
trains of thought to machine learning models (see below), 
but probably the two most popular, “main” branches are tree-
based and neural network-based algorithms. Deep learning 
methods are mostly neural networks of increased complex-
ity, capable of handling unprecedented amounts of data; a 
few illustrative examples from the world ADMET endpoints 
highlight their potential for multitask modeling (predicting 
multiple endpoints simultaneously) [17, 18].
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Tree‑based algorithms
Tree-based methods are very popular choices among 
machine learning techniques, not just in the field of ADME-
related in silico modeling. The basic concept of tree-based 
algorithms is the use of decision trees for classification (and 
also regression) models. The trees are constructed in the 
following way: recursive binary splits are performed on 
the dataset based on the different features, parent and child 
nodes are created in this way, and the samples are separated 
into classes based on the majority class of the members in 
the terminal nodes (without child nodes) [19, 20].
There are new ensemble alternatives of the simple deci-
sion trees, such as random forests or gradient boosted trees. 
In the case of random forests (RT), one can use a voting-
based combination of single decision trees for the classi-
fication of the objects with a better performance. Gradient 
boosting is an upgraded version, when the single decision 
trees are built sequentially with the boosting of the high per-
formance ones and the minimization of the errors [21]. The 
optimized version of gradient boosted trees is the extreme 
gradient boosted tree (XGBoost) method, which can handle 
missing values and with a much smaller chance to overfit-
ting. The tree-based algorithms are useful to handle complex 
nonlinear problems with imbalanced datasets, although in 
the case of noisy data they still tend to overfit. The hyperpa-
rameters (especially in XGBoost) should be tuned.
Neural networks
Artificial neural networks (ANNs) and their specialized ver-
sions such as deep neural networks (DNN) or deep learning 
(DL) are one of the most common algorithms in the machine 
learning field, for ADMET-related and other prediction tasks 
[22, 23]. The basic concept of the algorithm is inspired by 
the structure of the human brain. Neural networks consist of 
input layers, hidden layer(s) and output layer(s). The hidden 
layers include a number of neurons. Every input variable in 
the input layer has different weights. A nonlinear activation 
function helps to transform the different linear combina-
tion of the input nodes into the output value. The weights 
are optimized in an iterative process to decrease the error 
of the prediction, for example with feed-forward or back 
propagation.
The major difference between traditional neural networks 
and deep learning is the amount of data and the complexity 
of the network. DL networks usually consists of several hid-
den layers, while classical neural networks are using usually 
just one (or two). In DL, the molecular descriptors are trans-
formed into more abstract levels from layer to layer with the 
capability to manage complex functions. With such a com-
plex network, overfitting is a possibility thus the network 
should be tuned [18]. The problem of overfitting is managed 
in deep neural networks with different improvements such as 
dropout [24]. Neural networks can be used for both regres-
sion and classification problems, and the algorithm can 
handle missing values and incomplete data. Probably, the 
biggest disadvantage of the method is the so-called “black-
box” modeling; the user has little information on the exact 
role the provided inputs.
Support vector machine
Support vector machines (SVM) are a classical nonlinear 
algorithm for classification and regression modeling as well. 
The basic idea is the nonlinear mapping of the features in 
a higher dimensional space. A hyperplane is constructed in 
this space, which can define the class boundaries. Finding 
the optimal hyperplane needs some training data, and the 
so-called support vectors [25]. For the optimal separation 
by the hyperplanes, one should use a kernel function such 
as a radial basis function, a sigmoidal or a polynomial func-
tion [26]. Support vector machines can be applied for binary 
and multiclass problems as well. SVM works well in high 
dimensional data and the kernel function is a great strength 
of the method, although the interpretation of the weights and 
impact of the variables is difficult.
Naïve Bayes algorithms
Naïve Bayes algorithm is a supervised technique, which is 
based on the Bayesian theorem and the assumption of the 
uncorrelated (independent) features in the dataset. It also 
assumes that no hidden or latent variables influence the 
predictions (hence the name “naïve”) [27]. It is a simpler 
and faster algorithm compared to the other ML techniques; 
however, usually it has a cost in accuracy. Naïve Bayes algo-
rithms are connected to Bayesian networks as well. Individ-
ual probability values for each class are calculated to every 
object separately. The naïve Bayes algorithm is very fast, 
even in the big data era compared to the other algorithms, 
but it performs better in the less complex and “ideal” cases.
Nearest neighbor‑based algorithms
The k-nearest neighbor algorithm is one of the simplest 
and most commonly used classification methods [28, 29]. 
Simple, because this method only needs the calculation of 
distances between the ligand pairs in the dataset. In the case 
of k-nearest neighbors, the algorithm considers the group 
of k nearest compounds (objects) and classifies the com-
pounds/objects according to the majority votes in the class. 
Lots of variants are existing, such as N-nearest neighbors 
(N3), which is extended to all the n-1 compounds from k, 
or binned nearest neighbors (BNN) [30]. Nearest neighbor 
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type algorithms can be used for binary and multiclass clas-
sification, and regression as well. These algorithms are easy 
to understand and intuitive, but they are sensitive to outliers 
and imbalanced datasets.
ML models on the most prominent ADME 
targets
Several ADME and toxicity (ADMET) related endpoints 
have been selected for the comparative analysis of the last 
five years of research literature. Only classification mod-
els and categorical endpoints were selected, thus some 
important, but mostly regression-based models such as 
PAMPA or clearance are not covered by this review due 
to the different trends in these areas. Another focal point 
of this collection was to limit the considered studies to 
those with at least one thousand compounds. This way, 
we could provide a well-defined comparison among the 
trending algorithms and recent modeling habits.
hERG‑mediated cardiotoxicity
The human ether-à-go-go-related gene (hERG) encodes 
the α subunit of a voltage-gated potassium channel, which 
is one of the most important antitargets in drug discov-
ery, as the inhibition of this ion channel results in fatal 
arrhythmia (sudden cardiac death) by prolonging the QT 
interval of cardiac action potential [31]. As such, sig-
nificant research efforts are invested into screening com-
pounds against hERG inhibition and developing predictive 
models to avoid compounds with hERG liabilities in the 
first place. Conventionally, hERG inhibition is evaluated 
in patch-clamp electrophysiological assays [32, 33], with 
thallium-flux assays being a relatively new alternative [34, 
35]. The availability of large hERG inhibition datasets in 
PubChem Bioassay [36] and ChEMBL [37] allows for the 
development of reliable predictive models for hERG inhi-
bition, with wide applicability domains.
Here, we have collected 15 works from the past five 
years that employ machine learning-based classification 
approaches to predict hERG inhibition [38–51]. All of 
these works apply training datasets of more than 1,000 
molecules (and up to tens of thousands in some cases [47, 
48]), and an overall majority presents two-class (active vs. 
inactive) classification (with the notable example of the 
2015 study of Braga et al., who have introduced a third 
class of “weak blockers”) [38]. Categorizing the mole-
cules into the active and inactive classes is usually done 
by applying common activity thresholds such as 1 µM, 
10 µM or their combination, a comprehensive methodo-
logical comparison was presented by Siramshetty et al. 
[44]. Indeed, most of these works use the PubChem and 
ChEMBL databases as the data source, with a few exam-
ples of literature sources or other databases (NCATS, 
GOSTAR, etc.). Independently of the choice of software 
and machine learning methods, classification perfor-
mances are routinely great. The Comparative analysis 
section contains more details about the performance of 
the models.
Blood–brain barrier penetration
The blood–brain barrier (BBB) is formed by brain capil-
lary walls and glial cells to prevent harmful substances 
from entering the brain [52]. The penetration of this natural 
protective barrier of the central nervous system (CNS) by 
small molecules can be advantageous (in the case of CNS-
directed drug candidates where BBB passage is a require-
ment of drug action) or disadvantageous. As such, measur-
ing and predicting BBB penetration has been the focus of 
significant research efforts, particularly in CNS-related drug 
discovery [53]. As experimental data on BBB penetration is 
difficult to obtain, there are limited resources available for 
training machine learning models: there is relatively scarce 
data on BBB penetration in ChEMBL and PubChem Bioas-
say. Therefore, most studies rely on a limited number of core 
literature where experimental logBB (blood–brain distribu-
tion coefficient, log(cbrain/cblood)!) values of altogether a few 
thousand compounds are collected [54, 55].
Here, we have collected seven machine learning classifi-
cation studies from the past five years[56–62], with training 
sets of at least 1000 (and typically around 2000) compounds, 
employing popular machine learning methods such as ran-
dom forests of support vector machines. All of these studies 
apply a two-class (penetrant or BBB + vs. non-penetrant or 
BBB–) classification scenario, usually with logBB thresh-
olds of + 1, –1 or their combination. In addition to the most 
popular software choices and dedicated machine learning/
deep learning platforms, 2D molecule images also appear as 
an interesting choice for compound descriptors in the work 
of Shi et al. [60].
Permeability glycoprotein (P‑gp)
Permeability glycoprotein (P-gp) is a membrane protein that 
plays a pivotal role in the transport of a plethora of substrates 
through the cell membrane. This means that P-gp (which is 
expressed in blood–tissue and blood–brain barriers, among 
many other types of tissues like liver, colon, etc.) is of fun-
damental importance in pharmacokinetics, by regulating the 
efflux properties of a drug [63]. Coupled to ATP hydrolysis, 
P-gp can excrete several substrates out of the cell [64], this 
is why the over-expression of P-gp is a key factor in multid-
rug resistance [65]. Additionally, indiscriminate inhibition 
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of P-gp in liver tissue will interfere with the excretion of 
xenobiotics [17], potentially leading to hepatotoxicity. All 
this explains why much effort has been devoted to the study 
of P-gp inhibitors and substrates.
P-gp substrates and inhibitors are usually tested in sepa-
rate studies and naturally there are more studies with the 
focus on inhibitors [17, 66–72] instead of substrates [68, 
73]. The use of consensus modeling for this endpoint seems 
to be a viable option, a good example is the work of Yang 
et al. [72]. In another specific study of Prachayasittikul and 
coworkers [70], the authors used SMILES-based descriptors 
to build a novel classification model using the CORAL soft-
ware. The pseudo-regression model also shows great prom-
ise, with accuracy values over 80%, despite being relatively 
simple. Finally, among the most recent studies on P-gp inhi-
bition we have the work of Esposito et al. [73], which uses 
molecular dynamics fingerprints as descriptors. Overall, 
all methods performed very well, even external validation 
accuracies were above 0.70. A detailed comparison will be 
presented in the Comparative analysis section.
Cytochrome P450 enzyme family
The cytochrome P450 enzymes (CYP) have a crucial role 
in the metabolism of the xenobiotics. The CYP family of 
enzymes is also involved in drug safety and efficacy, because 
of the responsibility in drug-drug interactions (DDIs) [74]. 
In the human body, 57 different CYP isoforms can be found. 
Out of these, the most important six isoforms (CYP1A2, 
CYP2B6, CYP2C9, CYP2C19, CYP2D6 and CYP3A4) of 
the family metabolize more than 95% of the FDA-approved 
drugs [75].
In recent five years, several machine learning classifica-
tion models have been developed for the mentioned targets 
[76–83]. There are several online data sources with experi-
mental results (such as PubChem Bioassay) for the different 
isoenzymes separately and together as well. The classifica-
tion models are strongly connected to the PubChem Bio-
assay database: these datasets were used for almost every 
model, with one exception [77]. In one specific case, namely 
the 2C9 isoform, the collected dataset has reached even 
35 000 different molecules [74]. It should be emphasized, 
that the presence of the different CYP isoforms enables the 
development of multitarget classification models [80, 83]. 
The performances of the different models are discussed in 
detail later in the Comparative analysis section.
Acute oral toxicity
Acute toxicity can be defined as oral, dermal or inhalation, 
but out of the three types, oral toxicity is the most well-
known and thoroughly examined. It is an important endpoint 
from the early stage of drug discovery, since a compound 
that is hazardous for human health should be filtered out as 
early as possible [84]. Several machine learning models have 
been developed for the prediction of the median lethal dose 
 (LD50) values of the compounds in continuous (regression) 
and categorical (classification) setups as well. Rodents are 
the most common animals to test the median lethal dose of 
a compound, thus the usual datasets for machine learning 
modeling contain this type of data.
In our study, we have summarized the relevant classifica-
tion models [85–88]. Different guidelines help in the catego-
rization of the compounds in the different toxicity classes, 
such as the four-class system of the U.S. Environmental 
Protection Agency (EPA) [89] or the five-class version of 
the United Nations Globally Harmonized System of Clas-
sification and Labelling (GHS) [90]. Although multiclass 
classification is more frequent, one can find two-class clas-
sifications too, where the datasets are separated into very 
toxic or non-toxic (positive and negative) classes [87]. For 
this endpoint, the datasets usually contain more than ten 
thousand compounds and consensus models are frequently 
used. More details about these models are discussed later in 
the Comparative analysis section.
Carcinogenicity
Carcinogens are defined as chemical substances that can 
cause cancer and therefore, carcinogenicity is one of the 
most important toxicological endpoints, contributing even 
to the subsequent withdrawal of several approved drugs [91]. 
Carcinogenicity is usually tested in animal models [92], 
which, for ethical (and also economical) reasons, further 
underpins the importance of developing reliable predictive 
models to screen out potential carcinogenic liabilities early 
in the drug discovery process. As such, the prediction of car-
cinogenicity is the central topic of a vast literature, including 
early SAR and QSAR studies, and more recently, diverse 
machine learning approaches based on large training data-
sets [93–95]. It should be noted that structural alert-based 
systems can also achieve decent accuracies in carcinogenic-
ity prediction [96], further supporting the use of molecular 
fingerprints in predictive models (as it was dominated in the 
corresponding literature data from the past five years). All 
the evaluated models for this target are based on the Carci-
nogenic Potency Database [97].
Mutagenicity
Genetic toxicity testing is an early alternative of the carci-
nogenicity tests in the drug discovery processes. Bacterial 
tests are widespread methods in the pharma industry, and 
the Salmonella-reverse-mutation assay or Ames test is the 
in vitro gold standard for the task [98]. The Ames assay was 
developed by Bruce Ames and his colleagues almost fifty 
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years ago [99], and still this is the most important assay for 
the determination of the mutagenic potential of compounds. 
Most of the online mutagenicity databases are based on this 
in vitro experiment.
In the past five years, several machine learning classi-
fication models have been developed for this endpoint [43, 
100–103]. Most of them have applied six to seven thousand 
compounds for binary classification, mainly based on the 
Hansen Ames Salmonella mutagenicity benchmark data [104]. 
The performances were usually a bit lower compared to the 
other endpoints, especially in binary classification (see more 
details in the Comparative analysis section).
Respiratory toxicity
Chemical respiratory toxicity can cause serious harm for the 
human body; moreover, the effects are not always obvious in 
the early stages [105]. Respiratory toxicity can lead to symp-
toms such as asthma, bronchitis, pneumonia, rhinitis, etc. 
Unfortunately, pulmonary drug toxicity is possibly an under-
diagnosed cause of lung diseases. Therefore, it is also a major 
endpoint in ADMET studies. Naturally, in silico models can be 
useful alternatives to the usually applied animal experiments 
for the determination of respiratory toxicity.
We can find less publications compared to the other targets 
in the past few years [106–108], but performances are excel-
lent for this endpoint. It is also worth to note that the size 
of the datasets is much smaller compared to other endpoints. 
Some commonly used and publicly available databases from 
the publications are ChemIDplus (TOXNET) (chem.nlm.nih.
gov/chemidplus/), PNEUMOTOX (www. pneum otox. com) 
and ADrecs [109].
Irritation/corrosion
Another important topic is the examination of the skin and eye 
irritation effects of the different chemicals. REACH require-
ments should be fulfilled before a compound is entering the 
market (European legislation, (Regulation EC No 1907/2006)) 
[110]. This regulation includes the endpoints of skin and eye 
irritation and serious damage (corrosion). Corrosive com-
pounds can destroy the living tissues in the contact area (irre-
versible damage), while the irritative substances can cause 
inflammation (reversible damage) [111].
In this review, we have focused only on eye irritation. Eye 
irritation and corrosion experiments involve animal testing, 
preferably rabbits, but in silico approaches could potentially 
reduce the amount of animal testing in this case as well [110]. 
We have found three binary classification models from the 
past five years with more than one thousand compounds in 
the datasets [112, 113]. Gathering data for these endpoints is 
harder compared to other targets: usually several databases and 
literature data were merged into the final datasets for modeling.
Comparative analysis
In this review, 89 different models were evaluated from the 
relevant literature as a representative set. It is worth men-
tioning that only those relevant ADME and toxicity targets 
were used, where the potential use of classification models 
is supported, i.e., the target variable is categorical, such as 
inhibitor vs. non-inhibitor, toxic vs. non-toxic, etc. Our aim 
was to provide a comparison from the relevant publications 
of the last five years, when the authors used machine learn-
ing techniques in a combined or single mode for predicting 
different ADME-related endpoints in the big data era. The 
so-called “big data” formalism means different dataset sizes 
in science; thus, here we considered only those publications 
for the comparative study, where the datasets contained more 
than 1000 molecules. The gathering of the publications was 
closed on February 28, 2021. The final database of the mod-
els is shown in the Supplementary material.
Figure 1 shows the distribution among the different 
targets in the literature dataset. The CYP P450 isoforms 
(1A2, 2C9, 2C19, 2D6 and 3A4) were treated separately.
In the last five years in machine learning driven in silico 
classification modeling, the most frequent target was the 
drug metabolism related cytochrome P450 enzyme family. 
The distribution is closely uniform for the different isoforms, 
which can be attributed to the commonly used multi-targets 
in CYP P450 modeling. Another large proportion (17%) is 
connected to hERG (cardiotoxicity) modeling, since this 
target has a crucial role in drug safety as an antitarget and 
nowadays it is a routine procedure to test compounds for 
hERG-channel activity in the early stage of drug discovery.
Usually, more than one model is published in the 
papers, thus it is important to emphasize that only the best 
model for each target was evaluated from the publications 
in the following comparison.
The models were compared based on (i) the applied 
machine learning algorithm, (ii) the validation protocol, (iii) 
the used descriptor set, (iv) the modeling type (as consensus/
single), (v) the performance of the models and (vi) the data-
set size. Naturally, the authors did not always provide these 
parameters, thus missing values can occur in the dataset.
Consensus modeling means that the model was based 
on more than one machine learning algorithms and the 
authors applied various kinds of data fusion options for 
the development of the consensus model. It was interest-
ing to see that 80% of the models were based on a single 
algorithm. As consensus modeling is a very common field 
of in silico machine learning, we have no doubt about the 
increase of this type of models in the near future, espe-
cially for more complex targets.
In QSAR/QSPR modeling, the use of different molecu-
lar descriptors, fingerprint variants and other X variables, 
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such as docking score values or molecular dynamics sim-
ulation related variables has an important role. Several 
commercial software and publicly available tools offer the 
calculation of thousands of descriptors, and the selection 
of the appropriate ones can have a great effect in the final 
performance of the models. In Fig. 2, we have collected 
the used descriptor sets in the best models.
The most frequent combination was the application of 
classical 1D/2D/3D molecular descriptors with different 
fingerprints, which was followed by using only molecular 
descriptors and only fingerprints. Other descriptors, such 
as SMILES string related descriptors, molecular dynamics 
(MD) descriptors, 2D molecule images or docking score val-
ues are less frequently used, both alone and in combination 
with the other two favorite types.
Figure 3 shows the occurrences of the different machine 
learning algorithms. We have classified them into six differ-
ent groups: tree-based algorithms such as random forests, 
XGBoost, etc.; neural networks, which includes every 
algorithm with different network systems; support vector 
machine-based algorithms; nearest neighbor-based algo-
rithms, such as kNN, 3NN, etc.; Naïve Bayes algorithms; 
and the rest of them was classified as “Other”. It is impor-
tant to mention that in the consensus models, all of the used 
algorithms were classified into the related groups, thus the 
sum of the occurrences is higher than 89. (If the authors used 
more than one algorithm from the same type in a consensus 
model, it was counted only once.)
Tree-based algorithms have clearly dominated in silico 
classification modeling in the ADME world in the past five 
years. SVM and neural network-based algorithms are also 
very common, and only a little amount of models contained 
algorithms other than the first five group, like logistic regres-
sion, LDA, self-organizing maps, SIMCA, etc. [72, 86, 114].
The use of different validation practices for the veri-
fication of the models was a divisive factor among the 
Fig. 1  Distribution of the 
targets with percentages (BBB: 
blood–brain barrier)
Fig. 2  Occurrences of different descriptor types in the classification 
models 
Fig. 3  Occurrences of the different machine learning models in the 
collected dataset
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selected publications. We have checked the application of 
cross-validation (n-fold), internal validation and external 
validation alone, and in combination. Internal validation 
meant that the originally used database was split into two 
parts (training and test), while external validation meant 
that the authors used another database for the external ver-
ification of the model. Moreover, the training-test set splits 
were also evaluated when internal validation was used. 
Figure 4 shows the application of the validation types in 
the publications.
It is clear that only a relatively small number of pub-
lications used all three type of validation. In most cases, 
cross-validation was used in combination with external 
test validation. However, it is surprising that in fourteen 
cases, only internal validation was used, which is at least 
a questionable practice. Three models were validated 
only externally, which is also interesting, because with-
out internal or cross-validation, it does not reveal possible 
overfitting problems. Similar problems can be the use of 
only cross-validation, because in this case we do not know 
anything about model performance on “new” test samples.
Those models, where an internal validation set was used 
in any combination, were further analyzed based on the 
train–test splits (Fig. 5).
Most of the internal test validations used the 80/20 ratio 
for train/test splitting, which is in good agreement with our 
recent study about the optimal training-test split ratios [115]. 
Other common choices are the 75/25 and 70/30 ratios, and 
relatively few datasets were split in half. It is common sense 
that the more data we use for training, the better perfor-
mance we have–up to certain limits.
The dataset size was also an interesting factor in the com-
parison. Even though we had a lower limit of 1000 com-
pounds, we wanted to check the amount of the available data 
for the examined targets in the past few years. (We did one 
exception in the case of carcinogenicity, where a publication 
with 916 compounds was kept in the database, because there 
was a rather limited number of publications from the last five 
years in that case.) External test sets were added to the sizes 
of the datasets. Figure 6 shows the dataset sizes in a Box and 
Whisker plot with median, maximum and minimum values 
for each target.
The largest databases belong to the hERG target, while 
the smallest amount of data is connected to carcinogenicity. 
We can safely say that the different CYP isoforms, acute 
oral toxicity, hERG and mutagenicity are the most covered 
targets. On the other hand, it is an interesting observation 
that most models operate in the range between 2000 and 
10,000 compounds.
In the last section, we have evaluated the performance of 
the models for each target. Accuracy values were used for 
the analysis, which were not always given: in a few cases, 
only AUC, sensitivity or specificity values were determined, 
these were excluded from the comparisons. While accuracies 
were selected as the most common performance parameter, 
we know that model performance is not necessarily captured 
by only one metric. Figures 7 and 8 show the comparison of 
the accuracy values for cross-validation, internal validation 
and external validation separately. CYP P450 isoforms are 
plotted in Fig. 7, while Fig. 8 shows the rest of the targets.
For CYP targets, it is interesting to see that the accu-
racy of external validation has a larger range compared to 
internal and cross-validation, especially for the 1A2 iso-
form. However, dataset sizes were very close to each other 
in these cases, so it seems that this has no significant effect 
on model performance. Overall, accuracies are usually above 
0.8, which is appropriate for this type of models. In Fig. 8, 
the variability is much larger. While the accuracies for blood 
brain barrier (BBB), irritation/corrosion (eye), P-gp inhibi-
tor and hERG targets are very good, sometimes above 0.9, 
carcinogenicity and hepatotoxicity still need some improve-
ment in the performance of the models. Moreover, hepato-
toxicity has the largest range of accuracies for the models 
compared to the others.
Fig. 4  Occurrences of the different types of validations alone and in 
combination
Fig. 5  Occurrences of different split ratios in the train/test split of the 
datasets
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Average accuracies were compared with ANOVA anal-
ysis to show the effect of the different machine learning 
algorithms (only single models with one machine learn-
ing algorithm were included). Moreover, average absolute 
differences of the accuracies were calculated between CV 
and internal validation, CV and external validation and 
between external and internal validation (where it was pos-
sible). ANOVA analysis was also carried out on these val-
ues, which could present the difference in the robustness 
between the algorithms. Nearest neighbors algorithm was 
excluded from the comparison, because it was used only in 
consensus modeling.
Figure 9 shows the results of ANOVA. The machine 
learning algorithms have no significant effect on the mod-
els, but we have to note, that the variances are a bit bigger 
compared to the target related accuracies, due to the use of 
average values. On the other hand, in the case of the average 
absolute differences of the accuracies (b) a significant effect 
could be detected between the algorithms. We can observe 
that SVM and Neural networks have somewhat better 
Fig. 6  Dataset sizes for each 
examined target. Figure 6 A is 
the zoomed version of Fig. 6B, 
which is visually better for the 
targets with smaller dataset 
sizes. The number of molecules 
are plotted with the use of 
median, minimum and maxi-
mum values
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average accuracies, but their robustness is worse compared 
to the Tree-based and Naïve Bayes algorithms.
Resources
In the past decades, the role of the different programming 
languages and open-source platforms in QSAR/QSPR mod-
eling rapidly increased. Thus, it is not surprising that in the 
last five years, the most popular algorithms are connected 
to Python or R-based packages (see Fig. 10). One can find 
several machine learning packages for both platforms, how-
ever KNIME as a visual JAVA-based platform is also in this 
competition, because of the useful machine learning-related 
packages developed especially for classification problems. 
Several Python-based algorithms have KNIME implementa-
tions as well. One good example for this is Weka, which is 
also a well-known machine learning toolkit [116].
Fig. 7  Comparison of the 
accuracies for the different clas-
sification models for CYP P450 
isoforms. Median, minimum 
and maximum values are plotted 
for each target
Fig. 8  Comparison of the 
accuracies for the different 
ADME related targets. Median, 
minimum and maximum values 
are plotted
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We have compared the software/platform usages in our 
dataset, where the authors shared this information. Lib-
SVM (https:// www. csie. ntu. edu. tw/ ~cjlin/ libsvm/), Weka 
(https:// www. cs. waika to. ac. nz/ ml/ weka/) and Tensor-
flow (www. tenso rflow. org) software have several imple-
mentation options, thus we have decided to present these 
separately. Sometimes the authors have used more than 
one platform: these results are added separately to each 
segment. Almost half of the machine learning model 
developments are connected to either Python, R studio 
or KNIME. It is also worth to note, that Orange became 
a well-known open-source platform in the last couple of 
years [117]. Naturally, commercial software such as MAT-
LAB or Discovery Studio are covering a smaller portion. 
Other software includes all the standalone developments 
(open-source or commercial) such as ADMET predictor 
(Simulations Plus, Inc., www. simul ations- plus. com), 
PgpRules [68], CORAL [70] or Clementine (SPSS Inc., 
http:// www. spss. com). The latter ones had usually single 
occurrences in the dataset.
We cannot overlook several useful web-accessible tools 
for ADMET predictions, such as ADMETlab (http:// admet. 
scbdd. com) [118] or CypReact (https:// bitbu cket. org/ Leon_ 
Ti/ cypre act) [119], which are also based on several machine 
learning models, although this is not the main focus of this 
review.
Concluding remarks
The prediction of ADMET-related properties plays an 
important role in drug design as safety endpoints, and it 
seems that it will stay in this position for a long time. Sev-
eral of these drug safety targets are connected to harmful or 
deadly animal experiments, raising ethical concerns, moreo-
ver, the cost of most of these measurements is rather high. 
Thus, the use of in silico QSAR/QSPR models to overcome 
the problematic aspects of drug safety related experiments 
is highly supported.
The use of machine learning (artificial intelligence) algo-
rithms is a great opportunity in the QSAR/QSPR world for 
the reliable prediction of bioactivities on new and complex 
targets. Naturally, the increasing amount of publicly acces-
sible data is also helping to provide more reliable and exten-
sively applied models. In this review, we have focused on 
those models, which were based on bigger datasets (above 
one thousand molecules), to provide a comprehensive eval-
uation of the recent years’ ADMET-related models in the 
larger dataset segment. The findings showed the popularity 
Fig. 9  a b ANOVA analysis based on the a average accuracies and b average absolute differences of the accuracies. Machine learning algorithms 
are plotted in the X axis. The mean values and the 95% confidence intervals are shown in the figures.
Fig. 10  Comparison of the applied software packages
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of tree-based algorithms for classification problems. In the 
aspect of validation, many models still rely on only cross-
validation or only internal validation, which signifies a room 
for improvement in validation practices. The in silico predic-
tions of ADMET parameters have been, and will remain a 
central question of computational drug discovery and with 
the increasing databases, fast and efficient open-source 
platforms for modeling and the development of novel algo-
rithms, we believe that dedicated machine learning models 
have proven to be indispensable tools.
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